HAIFA, Israel, Nov. 23 /PRNewswire/ -- Elscint Ltd. (NYSE: ELT), a
subsidiary of Elbit Medical Imaging Ltd. (Nasdaq: EMITF), announced today,
that at the Shareholders Meeting, held on Friday, November 20, at the
Company's Headquarter in Haifa, approved by 99.4% the sale of its NM and MRI
businesses to GE Medical Systems (a division of GE) and its CT business to
Picker International Inc.
The transactions are still subject to various governmental approvals.
The Company believes that the closing of these deals will be held later
this week.
Elscint is an advanced medical imaging company serving healthcare
professionals worldwide. Guided by the philosophy of applying unique
technologies for the advancement of cost-effective healthcare, Elscint
designs, manufactures, sells and services a wide range of sophisticated
computer-based medical imaging products including Computerized Tomography
(CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine (NM) and Mammography
systems.
For further information on Elscint, via facsimile at no cost,
please call 1-800-PRO-INFO and enter company code 206 or ticker symbol ELT.
Internet home page: http://www.elscint.co.il
This release contains certain forward-looking statements which involve
known and unknown risks, uncertainties or other factors not under the
Company's control which may cause actual results, performance or achievements
of the Company to be materially different from the results, performance or
other expectations implied by these forward-looking statements. These factors
include, but are not limited to, those detailed in the Company's periodic
filings with the Securities and Exchange Commission.
SOURCE Elscint Ltd.
 back to top
Related links:
http://www.elscint.co.il
CONTACT:
Emmanuel Gill, President & CEO of Elscint,
972-4-855-0219; or General Info, Laurie Berman, 310-442-0599,
Media Info, Alicia Nieva-Woodgate, 415-986-1591, or Investor
Info, Brian Gill, 212-661-8030, all of The Financial Relations
Board
|
